Profil
P.
Martin Petkovich was the founder of Cytochroma, Inc. which was founded in 1996, where he held the title of Chief Scientific Officer from 2009 to 2012.
He also worked as a Principal at Queen's University.
Dr. Petkovich earned a doctorate degree from the University of Toronto in 1986 and an undergraduate degree from McMaster University in 1981.
Anciens postes connus de P. Martin Petkovich
Sociétés | Poste | Fin |
---|---|---|
Queen's University | Corporate Officer/Principal | - |
Cytochroma, Inc.
Cytochroma, Inc. Pharmaceuticals: MajorHealth Technology Cytochroma, Inc. is a clinical-stage specialty pharmaceutical company. It develops and markets prescription products for the prevention of vitamin D insufficiency. The firm specializes in pharmaceutical products to treat and prevent secondary hyperparathyroidism associated with chronic kidney disease. The company was founded by Martin J. Petkovich in 1996 and is headquartered in Markham, Canada. | Fondateur | - |
Formation de P. Martin Petkovich
McMaster University | Undergraduate Degree |
University of Toronto | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Cytochroma, Inc.
Cytochroma, Inc. Pharmaceuticals: MajorHealth Technology Cytochroma, Inc. is a clinical-stage specialty pharmaceutical company. It develops and markets prescription products for the prevention of vitamin D insufficiency. The firm specializes in pharmaceutical products to treat and prevent secondary hyperparathyroidism associated with chronic kidney disease. The company was founded by Martin J. Petkovich in 1996 and is headquartered in Markham, Canada. | Health Technology |